SNY vs SRTAW
SNY (SNY) versus Strata Critical Medical, Inc. (SRTAW) — a side-by-side from cached financials, not a winner call.
SNY (SNY) common stock.
Strata Critical Medical, Inc. (SRTAW) common stock listed on NASDAQ.
SNY does not have a complete income-statement cache yet.
Latest reported SRTAW revenue for 2024-12-31 was $248.7M. Net income was -$27.3M. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. SRTAW currently screens at market cap $0.
SNY currently screens at market cap $0. SRTAW currently screens at market cap $0.
Not investment advice. Open the SNY and SRTAW stock pages for the full models.
Not investment advice.